OBJECTIVE: The aim of the present study was to evaluate the therapeutic potency of an electrotherapy of striated ischiocavernous muscles in @entity1 with @entity323 . @entity1 AND METHODS: Transcutaneous electrostimulation of striated ischiocavernous muscles by self-adhesive penile or perineal skin electrodes was performed in 48 @entity1 with @entity323 . 6/48 @entity1 (R) responded to intracavernous pharmacotherapy while 42/48 (NR) did not show significant @entity2003 even to intracavernous @entity3302 / @entity5521 / @entity5015 triple drug medication. RESULTS: Within the observation time of 3 months, 10/48 @entity1 dropped out. 22/38 @entity1 reported a @entity2003 for sufficient sexual intercourse whereby 3/22 NR required additional intracavernous pharmacotherapy. @entity2003 could be objectivated by triple drug medicaton in 12/14 NR after ischiocavernous muscle stimulation (EIS) therapy. 5/6 R were treated successfully for premature erection loss. During EIS treatment neither discomfort nor complications could be observed. CONCLUSION: Transcutaneous electrostimulation of ischiocavernous muscles is a new, noninvasive therapy for the improvement of @entity2003 . The clinical results underline the importance of the striated ischiocavernous muscles for @entity2003 .

Treatment of XXXX by an external ischiocavernous muscle stimulator.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity323 :: ('MESH:D007172', 'Disease') :: ['erectile dysfunction'] @entity2003 :: ('MESH:D009127', 'Disease') :: ['penile rigidity', 'Penile rigidity'] @entity5521 :: ('MESH:D010646', 'Chemical') :: ['phentolamine'] @entity5015 :: ('MESH:D000527', 'Chemical') :: ['PGE1'] @entity3302 :: ('MESH:D010208', 'Chemical') :: ['papaverine']
@entity323 :: (MESH:D007172,Disease) :: ['erectile dysfunction']
